Clinical Trial Update: Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

View source ↗

Summary

A completed ECOG-ACRIN trial evaluated whether blood-based biomarkers can predict overall survival in patients with recurrent or metastatic head and neck cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Head and Neck Cancer | Status: COMPLETED